Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Aim. To evaluate late myelotoxicity (MT) relate to high-dose chemotherapy (CT) according to the modified NHL-BFM-90 (mNHL-BFM-90) program in adult patients with diffuse large B-cell lymphoma (DLBCL). Subjects and methods. The results of a complex clinical, laboratory, and instrumental examination, i...

Descrizione completa

Dettagli Bibliografici

Autori principali:	E I Dorokhina, A U Magomedova, V N Dvirnyk, I V Galtseva, S A Glinkina, S M Kulikov, T N Obukhova, S K Kravchenko
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	"Consilium Medicum" Publishing house 2016-07-01
Serie:	Терапевтический архив
Soggetti:	late myelotoxicity myelotoxicity high-dose chemotherapy mnhl-bfm-90 diffuse large b-cell lymphoma
Accesso online:	https://ter-arkhiv.ru/0040-3660/article/viewFile/31998/pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!